OKYO Pharma Ltd - Common (OKYO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common
Symbol
OKYO on Nasdaq
Shares outstanding
38,445,206
Price per share
$2.12
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,570,815
Total reported value
$5,141,930
% of total 13F portfolios
0%
Share change
-199,982
Value change
-$400,030
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of OKYO Pharma Ltd - Common (OKYO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 7.8% +14% $6,014,497 +$1,377,377 2,984,862 +30% Chernett Jorey 30 Sep 2025
Dauntless Investment Group, LLC 6.3% -14% $4,880,427 -$632,170 2,422,048 -11% Dauntless Investment Group, LLC 30 Sep 2025
Fonda Laura Natalia Monica 5% $3,856,902 1,928,451 LAURA NATALIA MONICA FONDA 22 Jul 2025

As of 30 Sep 2025, 8 institutional investors reported holding 2,570,815 shares of OKYO Pharma Ltd - Common (OKYO). This represents 6.7% of the company’s total 38,445,206 outstanding shares.

Institutional Holders of OKYO Pharma Ltd - Common (OKYO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,000 $21,200 $2.12 1
2025 Q3 2,570,815 $5,141,930 -$400,030 $2.00 8
2025 Q2 2,770,797 $1,479,794 +$329,427 $2.57 5
2025 Q1 2,075,082 $2,634,954 +$1,447,536 $1.27 7
2024 Q4 1,026,179 $1,179,953 +$28,548 $1.15 7
2024 Q3 1,001,353 $1,021,431 -$19,942 $1.03 6
2024 Q2 1,010,912 $1,210,177 +$115,592 $1.20 7
2024 Q1 913,582 $1,363,796 +$79,673 $1.50 6
2023 Q4 855,098 $1,513,021 +$1,343,703 $1.77 7
2023 Q3 95,254 $175,728 +$153,652 $1.85 7
2023 Q2 11,933 $13,669 +$13,669 $1.15 1